View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Loncastuximab Tesirin 150, diffuse large B-non-Hodgkin Lymphoma, cycle 1-2
Protocol-ID: 2229 V1.0 (Mini), LONTES150, DLBCL, C1-2Indication(s)
- NHL, B-Cell Type, Diffuse Large Cell; ICD-10 C83.3
Links
- Prescribing information for Loncastuximab Tesirin (ZYNLONTA) (FDA) [URL]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 21.04.2023